Cover Image
市場調查報告書

整形外科用骨水泥及鑄造材料:開發平台分析

Orthopedic Bone Cement - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 341588
出版日期 內容資訊 英文 106 Pages
訂單完成後即時交付
價格
Back to Top
整形外科用骨水泥及鑄造材料:開發平台分析 Orthopedic Bone Cement - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年04月01日 內容資訊: 英文 106 Pages
簡介

本報告提供全球各國的企業·醫療機關等正在開發的整形外科用骨水泥及鑄造材料之開發中產品資訊分析,提供您臨床實驗與產品開發的進展,各階段·各市場區隔·國家 (地區) 別趨勢,企業與產品詳細資訊,最近的產品開發及產業趨勢等資訊。

第1章 目錄

第2章 簡介

  • 整形外科用骨水泥及鑄造材料概要

第3章 開發中的產品

  • 整形外科用骨水泥及鑄造材料 - 各開發階段的開發中產品
  • 整形外科用骨水泥及鑄造材料 - 各市場區隔的開發中產品
  • 整形外科用骨水泥及鑄造材料 -國家 (地區) 別的開發中產品
  • 整形外科用骨水泥及鑄造材料 - 法規別的開發中產品
  • 整形外科用骨水泥及鑄造材料 - 核准時期 (估計) 別的開發中產品
  • 整形外科用骨水泥及鑄造材料 - 現在進行中的臨床實驗

第4章 整形外科用骨水泥及鑄造材料 - 正在開發的開發中產品:各企業

  • 整形外科用骨水泥及鑄造材料企業 - 各開發階段的開發中產品
  • 整形外科用骨水泥及鑄造材料 - 各開發階段的開發中產品

第5章 整形外科用骨水泥及鑄造材料企業與產品概要

  • aap Implantate AG
  • Bone Solutions, Inc.
  • Bone-Rad Therapeutics, Inc.
  • Exactech, Inc.
  • Graftys SAS
  • Medical Compression Systems (DBN) Ltd.
  • Meta Biomed Co., Ltd.
  • Onbone Oy
  • Orthox Ltd.
  • Osseon Therapeutics, Inc.
  • Ozics AG
  • Queen's University Belfast
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • Stryker Corporation
  • Synthes, Inc.
  • Teknimed S.A.
  • University of Limerick
  • Zimmer Biomet Holdings, Inc.

第6章 整形外科用骨水泥及鑄造材料 - 最近的趨勢

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0317EPD

GlobalData's Medical Devices sector report, "Orthopedic Bone Cement - Medical Devices Pipeline Assessment, 2017" provides an overview of Orthopedic Bone Cement currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and the number of trials for the key Orthopedic Bone Cement pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Orthopedic Bone Cement under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Orthopedic Bone Cement and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Orthopedic Bone Cement under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 6

2 Introduction 7

  • 2.1 Orthopedic Bone Cement Overview 7

3 Products under Development 8

  • 3.1 Orthopedic Bone Cement - Pipeline Products by Stage of Development 8
  • 3.2 Orthopedic Bone Cement - Pipeline Products by Segment 9
  • 3.3 Orthopedic Bone Cement - Pipeline Products by Territory 10
  • 3.4 Orthopedic Bone Cement - Pipeline Products by Regulatory Path 11
  • 3.5 Orthopedic Bone Cement - Pipeline Products by Estimated Approval Date 12

4 Orthopedic Bone Cement - Pipeline Products under Development by Companies 13

  • 4.1 Orthopedic Bone Cement Companies - Pipeline Products by Stage of Development 13
  • 4.2 Orthopedic Bone Cement - Pipeline Products by Stage of Development 14

5 Orthopedic Bone Cement Companies and Product Overview 15

  • 5.1 aap Implantate AG Company Overview 15
    • 5.1.1 aap Implantate AG Pipeline Products & Ongoing Clinical Trials Overview 15
  • 5.2 Biofix Medical Technologies Company Overview 17
    • 5.2.1 Biofix Medical Technologies Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.3 Bone-Rad Therapeutics, Inc. Company Overview 18
    • 5.3.1 Bone-Rad Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.4 DePuy Synthes Inc Company Overview 19
    • 5.4.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.5 Exactech Inc Company Overview 20
    • 5.5.1 Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.6 Graftys SA Company Overview 21
    • 5.6.1 Graftys SA Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.7 Meta Biomed Co Ltd Company Overview 23
    • 5.7.1 Meta Biomed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.8 Onbone Oy Company Overview 24
    • 5.8.1 Onbone Oy Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.9 Osseon Therapeutics Inc Company Overview 25
    • 5.9.1 Osseon Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.10 Ozics AG Company Overview 26
    • 5.10.1 Ozics AG Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.11 Queen's University Belfast Company Overview 28
    • 5.11.1 Queen's University Belfast Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.12 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 29
    • 5.12.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.13 Teknimed SA Company Overview 32
    • 5.13.1 Teknimed SA Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.14 University of Limerick Company Overview 34
    • 5.14.1 University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.15 Zimmer Biomet Holdings Inc Company Overview 36
    • 5.15.1 Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 36

6 Orthopedic Bone Cement- Recent Developments 37

  • 6.1 Mar 21, 2017: Medtronic Prices Public Offering of 1.7% Notes Due 2019 for USD1 Billion 37
  • 6.2 Mar 21, 2017: Medtronic Prices Public Offering of 3.35% Notes Due 2027 for USD850 Million 37
  • 6.3 Mar 21, 2017: Medtronic Prices Public Offering of 4.625% Notes Due 2045 for USD150 Million 38
  • 6.4 Mar 15, 2017: Alphatec Holdings Announces Fourth Quarter and Full Year 2016 Financial Results 38
  • 6.5 Mar 14, 2017: Medtronic Announces New Bone Cement Indication for Treating Sacral Fractures 39
  • 6.6 Mar 08, 2017: DJO Global Announces Financial Results for Fourth Quarter and Fiscal Year End 2016 40
  • 6.7 Mar 01, 2017: DJO Global Announces Appointment of Bryan McMillan as President, Regeneration 43
  • 6.8 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 43
  • 6.9 Feb 21, 2017: Exactech 2016 Revenue Up 7% to $257.6 Million, Q4'16 Revenue Increased 6% to $66.2 Million 46
  • 6.10 Feb 14, 2017: Alphatec Spine Announces Appointment of David H. Mowry to its Board of Directors 48
  • 6.11 Feb 09, 2017: Smith & Nephew Fourth Quarter Trading and Full Year 2016 Results 48
  • 6.12 Feb 09, 2017: Smith & Nephew: Directorate Change 54
  • 6.13 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 54
  • 6.14 Jan 31, 2017: Zimmer Biomet Reports Fourth Quarter and Full-Year 2016 Financial Results 55
  • 6.15 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook 56
  • 6.16 Jan 17, 2017: Zimmer Biomet Announces Americas Leadership Transition 57
  • 6.17 Jan 12, 2017: Stryker Prices Public Offering of 1.800% Notes Due 2019 for USD500 Million 58
  • 6.18 Jan 12, 2017: Zimmer Biomet Announces Resolution with DOJ and SEC Regarding Previously Disclosed Legacy Biomet FCPA Matters 58
  • 6.19 Jan 12, 2017: Confirmation of CFO leaving Smith & Nephew 58
  • 6.20 Jan 10, 2017: Stryker provides 2016 preliminary net sales results 59
  • 6.21 Jan 10, 2017: Zimmer Biomet Announces Fourth Quarter and Full-Year 2016 Preliminary Sales Results 60
  • 6.22 Dec 14, 2016: Zimmer Biomet Update on Product Supply Matters and Responsive Statement on Recently Completed FDA Inspection 61
  • 6.23 Dec 12, 2016: Alphatec Holdings appoints new CEO 61
  • 6.24 Dec 12, 2016: Alphatec Holdings Announces Board and Executive Leadership Changes 62
  • 6.25 Nov 30, 2016: Graham Baker appointed Chief Financial Officer 65
  • 6.26 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 65
  • 6.27 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 68
  • 6.28 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 69
  • 6.29 Nov 14, 2016: DJO Global Announces Appointment of Brady Shirley as President and Chief Executive Officer 69
  • 6.30 Nov 09, 2016: Alphatec Holdings Announces Third Quarter 2016 Revenue and Financial Results 70
  • 6.31 Nov 08, 2016: DJO Global Announces Financial Results for Third Quarter 73
  • 6.32 Nov 03, 2016: Smith & Nephew Third Quarter 2016 Trading Report 74
  • 6.33 Oct 31, 2016: Zimmer Biomet Reports Third Quarter 2016 Financial Results 76
  • 6.34 Oct 31, 2016: Exactech Q3 Revenue Up 7% to $59.9 Million. Net Income up 10% to $3.2 Million. Diluted EPS $0.22 vs. $0.20. 77
  • 6.35 Oct 27, 2016: Stryker reports third quarter 2016 results 78
  • 6.36 Oct 05, 2016: Alphatec Holdings Announces Company Updates 79
  • 6.37 Sep 15, 2016: Alphatec Holdings Announces Company Updates 80
  • 6.38 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 82
  • 6.39 Sep 06, 2016: DJO Global Announces Appointment of Mike Eklund as Chief Operating Officer and Chief Financial Officer 82
  • 6.40 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 83
  • 6.41 Aug 01, 2016: Exactech Q2 Revenue Up 8% to $66.1 Million; Net Income up 20% to $4.4 Million; Diluted EPS $0.31 vs. $0.26 86
  • 6.42 Jul 28, 2016: Smith & Nephew Second Quarter Trading and First Half 2016 Results 87
  • 6.43 Jul 28, 2016: Zimmer Biomet Reports Second Quarter 2016 Financial Results 90
  • 6.44 Jul 28, 2016: DJO Global Announces Financial Results for Second Quarter 2016 91
  • 6.45 Jul 21, 2016: Stryker reports second quarter 2016 results 92
  • 6.46 Jul 11, 2016: CFO to leave Smith & Nephew in early 2017 93
  • 6.47 Jul 06, 2016: Merit Medical Systems Acquires DFINE for USD97.5 Million 94
  • 6.48 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 94
  • 6.49 Jun 13, 2016: Zimmer Biomet Raises USD1.28 Billion in Public Offering of Shares 95
  • 6.50 Jun 07, 2016: Zimmer Biomet Raises USD532 Million in Public Offering of 2.42% Notes Due 2026 95
  • 6.51 Jun 07, 2016: Zimmer Biomet Raises USD532 Million in Public Offering of 1.4% Notes Due 2022 96
  • 6.52 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 96
  • 6.53 Jun 01, 2016: Osseon Expands Its Independent Distribution Network 97
  • 6.54 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 97
  • 6.55 May 10, 2016: DJO Global Announces Financial Results for First Quarter 2016 100
  • 6.56 Apr 20, 2016: Stryker reports first quarter 2016 results 101
  • 6.57 Mar 31, 2016: GRAFTYS strengthens its management and operations 102

7 Appendix 103

  • 7.1 Methodology 103
  • 7.2 About GlobalData 106
  • 7.3 Contact Us 106
  • 7.4 Disclaimer 106

List of Tables

1.1 List of Tables

  • Table 1: Orthopedic Bone Cement - Pipeline Products by Stage of Development 8
  • Table 2: Orthopedic Bone Cement - Pipeline Products by Segment 9
  • Table 3: Orthopedic Bone Cement - Pipeline Products by Territory 10
  • Table 4: Orthopedic Bone Cement - Pipeline Products by Regulatory Path 11
  • Table 5: Orthopedic Bone Cement - Pipeline Products by Estimated Approval Date 12
  • Table 6: Bone Cement Companies - Pipeline Products by Stage of Development 13
  • Table 7: Orthopedic Bone Cement - Pipeline Products by Stage of Development 14
  • Table 8: aap Implantate AG Pipeline Products & Ongoing Clinical Trials Overview 15
  • Table 9: Ag Cement - Product Status 15
  • Table 10: Ag Cement - Product Description 16
  • Table 11: Biofix Medical Technologies Pipeline Products & Ongoing Clinical Trials Overview 17
  • Table 12: Injectable Glass Ionomer Cement - Product Status 17
  • Table 13: Injectable Glass Ionomer Cement - Product Description 17
  • Table 14: Bone-Rad Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
  • Table 15: Spine-Rad Brachytherapy Bone Cement - Product Status 18
  • Table 16: Spine-Rad Brachytherapy Bone Cement - Product Description 18
  • Table 17: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 18: Statin Eluting Bone Cements - Product Status 19
  • Table 19: Statin Eluting Bone Cements - Product Description 19
  • Table 20: Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 21: Bone Cement - Product Status 20
  • Table 22: Bone Cement - Product Description 20
  • Table 23: Graftys SA Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 24: GRFT-M03 - Product Status 21
  • Table 25: GRFT-M03 - Product Description 21
  • Table 26: GRFT-M05 - Product Status 22
  • Table 27: GRFT-M05 - Product Description 22
  • Table 28: Meta Biomed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 29: Bone Cement - Product Status 23
  • Table 30: Bone Cement - Product Description 23
  • Table 31: Onbone Oy Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 32: BIOCEMENT - Product Status 24
  • Table 33: BIOCEMENT - Product Description 24
  • Table 34: Osseon Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 35: Monetite - Based Injectable Orthopaedic Cement - Product Status 25
  • Table 36: Monetite - Based Injectable Orthopaedic Cement - Product Description 25
  • Table 37: Ozics AG Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 38: CompO6 Bone Reinforcement Composite - Product Status 26
  • Table 39: CompO6 Bone Reinforcement Composite - Product Description 26
  • Table 40: CompO6 Reinforced Bone Composite - Osteoporotic Fractures - Product Status 27
  • Table 41: CompO6 Reinforced Bone Composite - Osteoporotic Fractures - Product Description 27
  • Table 42: Queen's University Belfast Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 43: Spinal Cement - Product Status 28
  • Table 44: Spinal Cement - Product Description 28
  • Table 45: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 46: BioCaS - Product Status 29
  • Table 47: BioCaS - Product Description 29
  • Table 48: Bone Cement - Product Status 30
  • Table 49: Bone Cement - Product Description 30
  • Table 50: Injectable Calcium Phosphate Cement - Product Status 30
  • Table 51: Injectable Calcium Phosphate Cement - Product Description 31
  • Table 52: Teknimed SA Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 53: Cemfix 1 - Product Status 32
  • Table 54: Cemfix 1 - Product Description 32
  • Table 55: Cemfix 3 - Product Status 33
  • Table 56: Cemfix 3 - Product Description 33
  • Table 57: University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 58: Bioactive Adhesive Cement - Product Status 34
  • Table 59: Bioactive Adhesive Cement - Product Description 34
  • Table 60: Dual Calcium Phosphate Paste System - Product Status 34
  • Table 61: Dual Calcium Phosphate Paste System - Product Description 35
  • Table 62: Heracap - Product Status 35
  • Table 63: Heracap - Product Description 35
  • Table 64: Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 65: Cobalt Stage One Acrylic Spacer Cement - Product Status 36
  • Table 66: Cobalt Stage One Acrylic Spacer Cement - Product Description 36
  • Table 67: Glossary 105

List of Figures

1.2 List of Figures

  • Figure 1: Orthopedic Bone Cement - Pipeline Products by Stage of Development 8
  • Figure 2: Orthopedic Bone Cement - Pipeline Products by Segment 9
  • Figure 3: Orthopedic Bone Cement - Pipeline Products by Territory 10
  • Figure 4: Orthopedic Bone Cement - Pipeline Products by Regulatory Path 11
  • Figure 5: Orthopedic Bone Cement - Pipeline Products by Estimated Approval Date 12
Back to Top